Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

The recent update to South Africa’s health-research ethics guidelines on heritable human genome editing has ignited ...

In light of one of the most polarizing elections a few days ago, we introduce some of the biggest science controversies in the past weeks.

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...

A new study has made significant strides in plant genome editing by developing an A-to-K base editing system for rice and ...

It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a potential new drug ...

Editas Medicine Inc. (EDIT) is a clinical-stage biotechnology company involved in developing genome treatments for rare ...

Currently, no country explicitly allows heritable human genome editing in clinical settings. It is not clear to what extent ...